This week’s Unusual Suspects are not just about earnings season, despite the deluge and onslaught we are about to see. We have a watch for events this week in shares of Acorda…
These are this morning’s top 10 pre-market analyst upgrades, downgrades, and initiations which we have seen early from Wall Street research firms: Acorda (NASDAQ: ACOR) Raised to Buy at Merriman Curhan Ford;…
These are this Friday morning’s top day trader and active trader alert stocks. We have provided a link through to VSInvestor.com with more detailed price and volume analysis on each stock below:…
These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street early this Wednesday morning: Acorda Therapeutics (ACOR) Raised to Overweight at Piper Jaffray. Coca-Cola Entertainment…
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is taking it right on the chin this morning. The company announced that it has received a “refuse to file letter” from the FDA regarding its New…
These are some of the top pre-market upgrades from analysts which we have seen in the early hours this Monday morning: Acorda Therapeutics (ACOR) Raised to Outperform at Baird. Biogen Idec (BIIB)…
Out of the daily movers this last week, many of the top winners and losers were from news in many of the smaller biotech stocks. We prepared a list of the winners…
Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would note that many of the…
Douglas A. McIntyre Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This data showed that Fampridine, which is designed to treat multiple sclerosis, did…
(ACOR) Acorda COO resigned to pursue other interests.(AMD) Advanced Micro Devices traded up 4% after revenues were ahead of plan on processor sales.(AUY) Yamana Gold makes business combination offer for Meridian Gold.(BVF)…
ACLI cut to Hold at Deutsche Bank.ACOR raised to Buy at B of A.AGO cut to Underweight at JPMorgan.ANAD started as Buy at Oppenheimer.ANET cut to Neutral at Baird.ATHR started as Buy…
(AAUK) Anglo American’s CEO will become a non-executive member of the board of directors at BP (BP).(ACAD) Acadia Pharmaceuticals traded up over 10% after Jim Cramer touted the stock as a speculative…
